SEOVF (Sernova Biotherapeutics) Change In Receivables : $0.10 Mil (TTM As of Jan. 2025)

View and export this data going back to 1998. Start your Free Trial

What is Sernova Biotherapeutics Change In Receivables?

Sernova Biotherapeutics's change in receivables for the quarter that ended in Jan. 2025 was $-0.05 Mil. It means Sernova Biotherapeutics's Accounts Receivable increased by $0.05 Mil from Oct. 2024 to Jan. 2025 .

Sernova Biotherapeutics's change in receivables for the fiscal year that ended in Oct. 2024 was $0.41 Mil. It means Sernova Biotherapeutics's Accounts Receivable declined by $0.41 Mil from Oct. 2023 to Oct. 2024 .

Sernova Biotherapeutics's Accounts Receivable for the quarter that ended in Jan. 2025 was $0.26 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sernova Biotherapeutics's liquidation value for the three months ended in Jan. 2025 was $-13.56 Mil.

Sernova Biotherapeutics Change In Receivables Historical Data

The historical data trend for Sernova Biotherapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics Change In Receivables Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Change In Receivables

Get a 7-Day Free Trial

0.01

-0.07

-0.14

0.17

0.41

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Change In Receivables	Get a 7-Day Free Trial															0.27	-0.36	0.31	0.20	-0.05

Sernova Biotherapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.10 Mil.

Sernova Biotherapeutics (OTCPK:SEOVF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sernova Biotherapeutics's Days Sales Outstanding for the quarter that ended in Jan. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.259	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Sernova Biotherapeutics's accounts receivable are only considered to be worth 75% of book value:

Sernova Biotherapeutics's liquidation value for the quarter that ended in Jan. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.84	-	14.599	+	0.75 * 0.259	+	0.5 * 0
=	-13.56

Sernova Biotherapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (OTCPK:SEOVF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

PSH0:Germany PSH0:Germany PSH0:Germany SVA:Canada

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.